2020.10.28

Partnership with SimpliFlying

Genomtec S.A. has started cooperation with Simpliflying, a leading aviation marketing consulting firm, as a result of participation in their ...
2020.10.23

Company’s share stock price set at PLN 11

The Management Board of Genomtec S.A. is pleased to inform that the series J share price has been set at PLN 11 per share. The issuing shares’ ...
2020.10.15

Smart Growth Operational Programme 2014-2020 – “Fast Track”

Project title:Developing a portable diagnostic device based on lab-on-chip analysis system to detect COVID-19 disease (SARS-CoV-2 pathogen). ...
2020.10.14

Genomtec starts public offer

Genomtec S.A. has launched an initial public offering of up to 730,000 J-series shares. The maximum price per share was agreed at PLN 11. The ...
2020.09.29

Genomtec S.A. presents its flagship diagnostic platform – Genomtec ID

Work on the mobile diagnostic platform – Genomtec ID, began in 2017 and currently we are starting its industrialization, proudly presenting ...
2020.09.25

Genomtec S.A. is being strengthened by joining key personnel – welcome to Jarek Oleszczuk, M.D., PhD, Marta Gajęcka and Jakub Swadźba, M.D., PhD.

Due to the dynamic growth in space the of company’s flagship project – Genomtec ID, the Management Board, fulfilling expectations of its ...